REDOXIS Trademark

Trademark Overview


On Thursday, April 11, 2019, a trademark application was filed for REDOXIS with the United States Patent and Trademark Office. The USPTO has given the REDOXIS trademark a serial number of 88381396. The federal status of this trademark filing is REGISTERED as of Tuesday, March 3, 2020. This trademark is owned by Redoxis AB. The REDOXIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; biological research, clinical research in the field of pharmaceuticals and medical research; pharmaceutical research services; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; medical laboratory services; laboratory research services relating to pharmaceuticals
redoxis

General Information


Serial Number88381396
Word MarkREDOXIS
Filing DateThursday, April 11, 2019
Status700 - REGISTERED
Status DateTuesday, March 3, 2020
Registration Number6000250
Registration DateTuesday, March 3, 2020
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, December 17, 2019

Trademark Statements


Indication of Colors claimedThe color(s) red and black is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the literal element "REDOXIS" in lowercase letters. To the left of "REDOXIS" is a stylized version of a lowercase "R" which is represented in red. The "X" in "REDOXIS" is also represented in red while the remaining letters are in black.
Goods and ServicesMedical research; biological research, clinical research in the field of pharmaceuticals and medical research; pharmaceutical research services; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; pharmaceutical research and development services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; medical laboratory services; laboratory research services relating to pharmaceuticals
Translation of Words in MarkThe wording "REDOXIS" has no meaning in a foreign language.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 29, 2019
Primary Code042
First Use Anywhere DateMonday, June 30, 2014
First Use In Commerce DateMonday, June 30, 2014

Trademark Owner History


Party NameRedoxis AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLund 22381
SE

Party NameRedoxis AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLund 22381
SE

Party NameRedoxis AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLund 22381
SE

Trademark Events


Event DateEvent Description
Tuesday, March 3, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, December 17, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 17, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 31, 2019ASSIGNED TO LIE
Friday, October 25, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 25, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 25, 2019NON-FINAL ACTION E-MAILED
Tuesday, June 25, 2019NON-FINAL ACTION WRITTEN
Friday, June 21, 2019ASSIGNED TO EXAMINER
Monday, April 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 15, 2019NEW APPLICATION ENTERED IN TRAM